Description

(6,7-Dimethoxy-2-Oxo-1,2,3,4-Tetrahydroquinolin-4-Yl)Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily sought by research institutions and manufacturers in the pharmaceutical and fine chemical industries engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug candidates, especially those targeting the central nervous system or possessing kinase inhibitory activity.
• Organic Synthesis Building Block: Used in research-scale and process chemistry for constructing quinoline and tetrahydroquinoline-based molecular frameworks.
• Medicinal Chemistry Research: Serves as a versatile scaffold for generating compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation in API manufacturing.
• Biochemical Research: Potential use as a tool compound for investigating biological pathways and enzyme interactions in vitro.

Basic Information

Product Name	(6,7-Dimethoxy-2-Oxo-1,2,3,4-Tetrahydroquinolin-4-Yl)Acetic Acid
CAS No.	1160264-02-7
Molecular Formula	C₁₄H₁₅NO₆
Molecular Weight	293.27 g/mol
Synonyms	4-(Carboxymethyl)-6,7-dimethoxy-3,4-dihydro-2(1H)-quinolinone; 2-(6,7-Dimethoxy-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl)acetic acid; 4-Acetic acid-6,7-dimethoxy-1,2,3,4-tetrahydro-2-quinolinone; (6,7-Dimethoxy-2-oxo-1,2,3,4-tetrahydro-4-quinolyl)acetic acid; 4-Quinolineacetic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-oxo-; 1160264-02-7
EINECS	Contact for details

Quality Control

Our (6,7-Dimethoxy-2-Oxo-1,2,3,4-Tetrahydroquinolin-4-Yl)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical R&D and production. Certificates of Analysis (COA) detailing all test results are provided and can be tailored to meet specific client or regulatory standards.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.